Compare MGM Resorts International (MGM) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs Revvity Inc — how do they compare? MGM Resorts International trades at $40.18 (market cap $10.25B), while Revvity Inc trades at $124.14 (market cap $14.18B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays the higher dividend (0.22%). Which is the better fit depends on your goals.
| MGM | RVTY | |
|---|---|---|
Market Cap | $10.25B | $14.18B |
Sector | Consumer Cyclical | Technology |
52-Week High | $50.69 | $130.94 |
52-Week Low | $30.72 | $82.26 |
Enterprise Value | $37.55B | $16.50B |
Dividend Yield | 0.03% | 0.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International trades at $40.74, down 1.16% on the day, as the stock faces technical bearish pressure despite strong analyst support. The company reported mixed quarterly earnings with two beats and one miss in recent quarters, while maintaining stable revenue around $17.5 billion. Recent news highlights include BetMGM's football season enhancements and ongoing investigation into Barry Diller's $48.30 per share acquisition offer.
MGM presents a compelling valuation case with a P/S ratio of 0.61 below industry averages, supported by 51% analyst buy ratings and a $51.61 consensus price target offering 27% upside. However, declining profit margins and negative cash flow trends pose fundamental concerns, while the bearish technical outlook suggests near-term pressure. The acquisition investigation adds regulatory uncertainty to the investment thesis.
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
